FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Phyllis Warkentin

Research Profile

Procedures

Anatomy

Living Beings

Infants

Disorders

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Dumrul Gulen; Fuminori Abe; Sarah Maas; Elizabeth Reed; Kenneth Cowan; Samuel J Pirruccello; James Wisecarver; Phyllis I Warkentin; Matt Northam; Orhan Turken; Ugur Coskun; Joe Senesac; James Edward Talmadge
Closing the manufacturing process of dendritic cell vaccines transduced with adenovirus vectors.
Simon Horslen; Timothy C McCowan; Timothy C Goertzen; Phyllis I Warkentin; Hung Bo Cai; Stephen C Strom; Ira J Fox
Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder.
Phyllis I Warkentin
Voluntary accreditation of cellular therapies: Foundation for the Accreditation of Cellular Therapy (FACT).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Phyllis Warkentin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Dumrul Gulen; Fuminori Abe; Sarah Maas; Elizabeth Reed; Kenneth Cowan; Samuel J Pirruccello; James Wisecarver; Phyllis I Warkentin; Matt Northam; Orhan Turken; Ugur Coskun; Joe Senesac; James Edward Talmadge
Closing the manufacturing process of dendritic cell vaccines transduced with adenovirus vectors.
International immunopharmacology 2008;8(13-14):1728-36.
2003: Simon Horslen; Timothy C McCowan; Timothy C Goertzen; Phyllis I Warkentin; Hung Bo Cai; Stephen C Strom; Ira J Fox
Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder.
Pediatrics 2003;111(6 Pt 1):1262-7.
2003: Phyllis I Warkentin
Voluntary accreditation of cellular therapies: Foundation for the Accreditation of Cellular Therapy (FACT).
Cytotherapy 2003;5(4):299-305.
2003: Phyllis I Warkentin
Hematopoietic stem and progenitor cell transplants: regulation and accreditation.
Pediatric transplantation 2003;7 Suppl 3():101-8.
2001: M Hirai; Drake LaFace; Simon Robinson; LS Kelsey; R Johnson; Shu Fen Wen; Phyllis I Warkentin; K Mills; Mei Ting Vaillancourt; Jennifer Chavez; Cheryl Leutzinger; Janos Sumegi; S Neugebauer; J Lehman; Catherine B Talmadge; Daniel Maneval; James Edward Talmadge
Ex vivo purging by adenoviral p53 gene therapy does not affect NOD-SCID repopulating activity of human CD34+ cells.
Cancer gene therapy 2001;8(12):936-47.
2001: Ronald J Rubocki; J R Parsa; Michael S Hershfield; Warren G Sanger; Samuel J Pirruccello; Ines Santisteban; Bruce G Gordon; S E Strandjord; Phyllis I Warkentin; Peter F Coccia
Full hematopoietic engraftment after allogeneic bone marrow transplantation without cytoreduction in a child with severe combined immunodeficiency.
Blood 2001;97(3):809-11.
2000: Shantaram S Joshi; K Miller; John D Jackson; Phyllis I Warkentin; Anne Kessinger
Immunological properties of mononuclear cells from blood stem cell harvests following mobilization with erythropoietin + G-CSF in cancer patients.
Cytotherapy 2000;2(1):15-24.
2000: Phyllis I Warkentin; L Nick; E J Shpall
FAHCT accreditation: common deficiencies during on-site inspections.
Cytotherapy 2000;2(3):213-20.
1999: Samuel J Pirruccello; C J Page; Michael Bishop; B A Letheby; Phyllis I Warkentin; John D Jackson; Anne Kessinger
Comparison of ISHAGE protocol CD34 cell enumeration with a lineage negative backgating technique.
Cytotherapy 1999;1(4):279-86.
1999: AG Ageitos; Michelle L Varney; Philip J Bierman; Julie M Vose; Phyllis I Warkentin; James Edward Talmadge
Comparison of monocyte-dependent T cell inhibitory activity in GM-CSF vs G-CSF mobilized PSC products.
Bone marrow transplantation 1999;23(1):63-9.
1998: Ira J Fox; Jayanta Roy-Chowdhury; Stuart S Kaufman; Timothy C Goertzen; Namita Roy-Chowdhury; Phyllis I Warkentin; K Dorko; BV Sauter; Stephen C Strom
Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation.
The New England journal of medicine 1998;338(20):1422-6.
1998: Z Steven Pavletic; Shantaram S Joshi; Samuel J Pirruccello; stefano r tarantolo; JP Kollath; Elizabeth C Reed; Philip J Bierman; Julie M Vose; Phyllis I Warkentin; Thomas G Gross; K Nasrati; James O Armitage; Anne Kessinger; Michael Bishop
Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies.
Bone marrow transplantation 1998;21(1):33-41.
1997: Michael Bishop; John D Jackson; stefano r tarantolo; B O'Kane-Murphy; Patrick L Iversen; E Bayever; S M Joshi; J Graham Sharp; J L Pierson; Phyllis I Warkentin; James O Armitage; Anne Kessinger
Ex vivo treatment of bone marrow with phosphorothioate oligonucleotide OL(1)p53 for autologous transplantation in acute myelogenous leukemia and myelodysplastic syndrome.
Journal of hematotherapy 1997;6(5):441-6.
1997: Bruce G Gordon; Phyllis I Warkentin; S E Strandjord; MA Abromowitch; E Bayever; James L Harper; Peter F Coccia
Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
Bone marrow transplantation 1997;20(1):5-10.
1997: Michael Bishop; stefano r tarantolo; John D Jackson; James Robert Anderson; K Schmit-Pokorny; D Zacharias; Z Steven Pavletic; Samuel J Pirruccello; Julie M Vose; Philip J Bierman; Phyllis I Warkentin; James O Armitage; Anne Kessinger
Allogeneic-blood stem-cell collection following mobilization with low-dose granulocyte colony-stimulating factor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1601-7.
1996: Michael Bishop; John D Jackson; B O'Kane-Murphy; K Schmit-Pokorny; Julie M Vose; Philip J Bierman; Phyllis I Warkentin; James O Armitage; L Garrison; Anne Kessinger
Phase I trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cells.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(9):2521-6.
1995: Anne Kessinger; Michael Bishop; John D Jackson; B O'Kane-Murphy; Julie M Vose; Philip J Bierman; Elizabeth C Reed; Phyllis I Warkentin; James O Armitage; J Graham Sharp
Erythropoietin for mobilization of circulating progenitor cells in patients with previously treated relapsed malignancies.
Experimental hematology 1995;23(7):609-12.
1995: Anne Kessinger; Michael Bishop; James Robert Anderson; James O Armitage; Philip J Bierman; Elizabeth C Reed; stefano r tarantolo; M A Tempero; Julie M Vose; Phyllis I Warkentin
Comparison of subcutaneous and intravenous administration of recombinant human granulocyte-macrophage colony-stimulating factor for peripheral blood stem cell mobilization.
Journal of hematotherapy 1995;4(2):81-4.
1994: Thomas G Gross; F J Hoge; John D Jackson; P H Sammut; Phyllis I Warkentin
Fatal eosinophilic disease following autologous bone marrow transplantation.
Bone marrow transplantation 1994;14(2):333-7.
1994: Michael Bishop; James Robert Anderson; John D Jackson; Philip J Bierman; Elizabeth C Reed; Julie M Vose; James O Armitage; Phyllis I Warkentin; Anne Kessinger
High-dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograft.
Blood 1994;83(2):610-6.
1994: B Jershin; John D Jackson; K Schmidt-Pokorny; Phyllis I Warkentin
Hematopoietic progenitor cells frozen in ampules are satisfactory reference vials for bulk freezing.
Progress in clinical and biological research 1994;389():657-61.
1994: Phyllis I Warkentin; John D Jackson; B Letheby; Anne Kessinger
Effective cryopreservation of cytokine-mobilized autologous peripheral blood stem cells using non-controlled rate freezing.
Progress in clinical and biological research 1994;389():643-7.
1994: Michael Bishop; Phyllis I Warkentin; John D Jackson; E Bayever; Patrick L Iversen; V I Whalen; J Lastovica; K Haines; Anne Kessinger
Antisense oligonucleotide OL (1) p53 for in vitro purging of autologous bone marrow in acute myelogenous leukemia.
Progress in clinical and biological research 1994;389():183-7.
1994: John D Jackson; B Letheby; B O'Kane Murphy; P Costas; P N Wang; Michael Bishop; Anne Kessinger; Phyllis I Warkentin
Kinetics of low and high dose granulocyte/macrophage colony stimulating factor mobilization of peripheral blood stem cells.
Progress in clinical and biological research 1994;389():471-7.
1994: R Alter; B O'Kane-Murphy; D Korth; P Costas; P N Wang; L Welniak; J F Greally; Charles A Kuszynski; Phyllis I Warkentin; John D Jackson
Characterization of hematopoietic stem cells in human cord blood.
Progress in clinical and biological research 1994;389():393-8.
1994: B O'Kane-Murphy; John D Jackson; Charles A Kuszynski; P Costas; P N Wang; Phyllis I Warkentin; Anne Kessinger
CD34 analysis in erythropoietin mobilized peripheral blood stem cells.
Progress in clinical and biological research 1994;389():371-6.
1993: Philip J Bierman; Phyllis I Warkentin; M R Hutchins; L W Klassen
Pure red cell aplasia following ABO mismatched marrow transplantation for chronic lymphocytic leukemia: response to antithymocyte globulin.
Leukemia & lymphoma 1993;9(1-2):169-71.
1993: Bruce G Gordon; Dennis D Weisenburger; Phyllis I Warkentin; J Anderson; Warren G Sanger; M Bast; D Gnarra; Julie M Vose; Philip J Bierman; James O Armitage
Peripheral T-cell lymphoma in childhood and adolescence. A clinicopathologic study of 22 patients.
Cancer 1993;71(1):257-63.
1992: Bruce G Gordon; Phyllis I Warkentin; Dennis D Weisenburger; Julie M Vose; Warren G Sanger; S E Strandjord; James Robert Anderson; J D Verdirame; Philip J Bierman; James O Armitage
Bone marrow transplantation for peripheral T-cell lymphoma in children and adolescents.
Blood 1992;80(11):2938-42.
1992: B Letheby; J Jackson; J Greally; Phyllis I Warkentin; Douglas Smith; Julie M Vose; Philip J Bierman; Anne Kessinger; P Coccia; J Armitage
Comparison of two methods of bone marrow processing for autologous bone marrow transplantation.
Progress in clinical and biological research 1992;377():345-51.
1991: W P Vaughan; J D Dennison; Elizabeth C Reed; L Klassen; Timothy R McGuire; Warren G Sanger; P P Kumar; Phyllis I Warkentin; Bruce G Gordon; Philip J Bierman
Improved results of allogeneic bone marrow transplantation for advanced hematologic malignancy using busulfan, cyclophosphamide and etoposide as cytoreductive and immunosuppressive therapy.
Bone marrow transplantation 1991;8(6):489-95.
1991: Bruce G Gordon; Kay Linn Saving; J A McCallister; Phyllis I Warkentin; J R McConnell; W M Roberts; Peter F Coccia; William D Haire
Cerebral infarction associated with protein C deficiency following allogeneic bone marrow transplantation.
Bone marrow transplantation 1991;8(4):323-5.
1991: Bruce G Gordon; S E Strandjord; Phyllis I Warkentin; J Kadushin; Peter F Coccia
Successful treatment of severe aplastic anemia by bone marrow transplantation from HLA nonidentical family members: preliminary results utilizing cyclophosphamide and 600 cGY fractionated total body irradiation.
The American journal of pediatric hematology/oncology 1991;13(1):29-33.
1989: Anne Kessinger; Douglas Smith; S E Strandjord; J D Landmark; D C Dooley; P Law; Peter F Coccia; Phyllis I Warkentin; Dennis D Weisenburger; James O Armitage
Allogeneic transplantation of blood-derived, T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia.
Bone marrow transplantation 1989;4(6):643-6.
1989: J Stein; Peter Zimmerman; M Kochera; S Strandjord; W Golden; M Simon; Phyllis I Warkentin; B R Blazar; P Coccia; Naomi Lang-Unnasch
Origin of leukemic relapse after bone marrow transplantation: comparison of cytogenetic and molecular analyses.
Blood 1989;73(7):2033-40.
1988: Peter F Coccia; S E Strandjord; Phyllis I Warkentin; Nai-Kong V Cheung; E M Gordon; L J Novak; D C Shina; R H Herzig
High-dose cytosine arabinoside and fractionated total-body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission.
Blood 1988;71(4):888-93.
1988: J Stein; S Strandjord; U Saarinen; Phyllis I Warkentin; Stanton L Gerson; H Lazarus; Daniel Von Hoff; P Coccia; Nai-Kong V Cheung
In vitro treatment of autologous bone marrow for neuroblastoma patients with anti GD2 monoclonal antibody and human complement: a pilot study.
Progress in clinical and biological research 1988;271():237-48.
1987: U M Saarinen; S E Strandjord; Phyllis I Warkentin; Nai-Kong V Cheung; H M Lazarus; Peter F Coccia
Differentiation of presumed sepsis from acute graft-versus-host disease by C-reactive protein and serum total IgE in bone marrow transplant recipients.
Transplantation 1987;44(4):540-6.
1987: R J Berkowitz; S Strandjord; P Jones; C Hughes; J Barsetti; E M Gordon; Nai-Kong V Cheung; Phyllis I Warkentin; Peter F Coccia
Stomatologic complications of bone marrow transplantation in a pediatric population.
Pediatric dentistry 1987;9(2):105-10.
1985: R H Herzig; Peter F Coccia; H M Lazarus; S E Strandjord; John Graham-Pole; Nai-Kong V Cheung; E M Gordon; S Gross; T R Spitzer; Phyllis I Warkentin
Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiation.
Seminars in oncology 1985;12(2 Suppl 3):184-6.
1985: Nai-Kong V Cheung; U Saarinen; J Neely; FD Miraldi; S Strandjord; Phyllis I Warkentin; P Coccia
Development of neuroblastoma monoclonal antibodies for potential utilization in diagnosis and therapy.
Progress in clinical and biological research 1985;175():501-5.
1985: R J Berkowitz; C Hughes; M Rudnick; E M Gordon; S Strandjord; Nai-Kong V Cheung; Phyllis I Warkentin; Peter F Coccia
Oropharyngeal Candida prophylaxis in pediatric bone marrow transplant patients.
The American journal of pediatric hematology/oncology 1985;7(1):82-6.
1984: H M Lazarus; Peter F Coccia; R H Herzig; John Graham-Pole; S Gross; S Strandjord; E Gordon; Nai-Kong V Cheung; Phyllis I Warkentin; T R Spitzer
Incidence of acute graft-versus-host disease with and without methotrexate prophylaxis in allogeneic bone marrow transplant patients.
Blood 1984;64(1):215-20.
1980: J H Kersey; T Kim; S Levitt; W Krivit; M E Nesbit; P Coccia; Phyllis I Warkentin; M O'Leary; N K Ramsay
Combined immunosuppression using cyclophosphamide plus total lymphoid irradiation in preparation for allogeneic marrow transplantation in humans.
Haematology and blood transfusion 1980;25():333-8.